Cidara Thera (NQ: CDTX )

2.160 USD UNCHANGED

Streaming Delayed Price Updated: 7:31 PM EDT, Apr 14, 2021 Add to My Watchlist

Price and Volume

Volume	0
Open	2.160
Bid (Size)	2.180 (2)
Ask (Size)	2.210 (1)
Prev. Close	2.160
Today's Range	2.160 - 2.160
52wk Range	1.820 - 4.450
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Cidara Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference

April 07, 2021

Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza

April 05, 2021

Performance

YTD	+4.85%	+4.85%
1 Month	-17.24%	-17.24%
3 Month	-9.24%	-9.24%
6 Month	-27.27%	-27.27%
1 Year	-22.58%	-22.58%

More News

Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 01, 2021

Cidara Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference

March 03, 2021

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results

February 25, 2021

UTILITY Therapeutics Joins Antimicrobials Working Group

February 17, 2021

Cidara Therapeutics Announces New Data for Rezafungin at the 21st ICHS Symposium

February 17, 2021

Cidara Therapeutics to Present New Data for Rezafungin and Influenza AVCs at the 21st ICHS Symposium

February 11, 2021

Cidara Therapeutics Announces Key Additions to its Board of Directors

January 25, 2021

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 05, 2021

Cidara Therapeutics Appoints Biotechnology Industry Veteran Christopher Kurtz As Executive Vice President of Technical Operations

December 15, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.